A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels

Maria Sabater-Lleal, Alfonso Buil, Juan Carlos Souto, Laura Alamsy, Montserrat Borrell, Mark Lathrop, John Blangero, Jordi Fontcuberta, José Manuel Soria

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) is a protein that potently attenuates fibrinolysis. A considerable proportion of its variability levels is genetically determined. It has been associated with arterial and venous thrombosis. We conducted a Genome Wide Scan for genes affecting variation in plasma TAFI levels in 398 subjects from 21 extended Spanish families. The data were analyzed by a variance-component linkage method. A strong linkage signal was found on the long arm of Chromosome 13, near the DNA marker D13S156, where the structural gene encoding for TAFI is located. In addition, other new linkage signals were detected on chromosome regions 5p and 7q. More importantly, we performed another multipoint linkage analysis of functional TAFI conditioned on TAFI antigen levels. We detected a strong linkage signal on Chromosome 19 (LOD = 3.0, P = 0.0001) suggesting a novel QTL in this region involved in the specific functional activity of TAFI, regardless of the TAFI antigen levels. One notable aspect of this study is the identification of new QTLs that reveal a clearer picture of the genetic determinants responsible for variation in TAFI levels. Another is the replication of the linkage signal of the CPB2 gene, which confirms an important genetic determinant for TAFI antigen levels. These results strongly suggest an oligogenic mode of inheritance for TAFI, in which CPB2 gene accounts for a proportion of the variation of the phenotype together with other unknown genes that may represent potential risk factors for thrombotic disease.

Original languageEnglish (US)
Pages (from-to)81-88
Number of pages8
JournalHuman Genetics
Volume124
Issue number1
DOIs
StatePublished - Aug 2008
Externally publishedYes

Fingerprint

Carboxypeptidase B2
Multifactorial Inheritance
Genome
Antigens
Genes
Chromosomes, Human, Pair 19
Chromosomes, Human, Pair 13
Fibrinolysis
Genetic Markers
Venous Thrombosis
Chromosomes

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Cite this

Sabater-Lleal, M., Buil, A., Souto, J. C., Alamsy, L., Borrell, M., Lathrop, M., ... Soria, J. M. (2008). A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels. Human Genetics, 124(1), 81-88. https://doi.org/10.1007/s00439-008-0527-3

A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels. / Sabater-Lleal, Maria; Buil, Alfonso; Souto, Juan Carlos; Alamsy, Laura; Borrell, Montserrat; Lathrop, Mark; Blangero, John; Fontcuberta, Jordi; Soria, José Manuel.

In: Human Genetics, Vol. 124, No. 1, 08.2008, p. 81-88.

Research output: Contribution to journalArticle

Sabater-Lleal, M, Buil, A, Souto, JC, Alamsy, L, Borrell, M, Lathrop, M, Blangero, J, Fontcuberta, J & Soria, JM 2008, 'A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels', Human Genetics, vol. 124, no. 1, pp. 81-88. https://doi.org/10.1007/s00439-008-0527-3
Sabater-Lleal, Maria ; Buil, Alfonso ; Souto, Juan Carlos ; Alamsy, Laura ; Borrell, Montserrat ; Lathrop, Mark ; Blangero, John ; Fontcuberta, Jordi ; Soria, José Manuel. / A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels. In: Human Genetics. 2008 ; Vol. 124, No. 1. pp. 81-88.
@article{db026087cf994e82bcc104a2f88fbed6,
title = "A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels",
abstract = "Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) is a protein that potently attenuates fibrinolysis. A considerable proportion of its variability levels is genetically determined. It has been associated with arterial and venous thrombosis. We conducted a Genome Wide Scan for genes affecting variation in plasma TAFI levels in 398 subjects from 21 extended Spanish families. The data were analyzed by a variance-component linkage method. A strong linkage signal was found on the long arm of Chromosome 13, near the DNA marker D13S156, where the structural gene encoding for TAFI is located. In addition, other new linkage signals were detected on chromosome regions 5p and 7q. More importantly, we performed another multipoint linkage analysis of functional TAFI conditioned on TAFI antigen levels. We detected a strong linkage signal on Chromosome 19 (LOD = 3.0, P = 0.0001) suggesting a novel QTL in this region involved in the specific functional activity of TAFI, regardless of the TAFI antigen levels. One notable aspect of this study is the identification of new QTLs that reveal a clearer picture of the genetic determinants responsible for variation in TAFI levels. Another is the replication of the linkage signal of the CPB2 gene, which confirms an important genetic determinant for TAFI antigen levels. These results strongly suggest an oligogenic mode of inheritance for TAFI, in which CPB2 gene accounts for a proportion of the variation of the phenotype together with other unknown genes that may represent potential risk factors for thrombotic disease.",
author = "Maria Sabater-Lleal and Alfonso Buil and Souto, {Juan Carlos} and Laura Alamsy and Montserrat Borrell and Mark Lathrop and John Blangero and Jordi Fontcuberta and Soria, {Jos{\'e} Manuel}",
year = "2008",
month = "8",
doi = "10.1007/s00439-008-0527-3",
language = "English (US)",
volume = "124",
pages = "81--88",
journal = "Human Genetics",
issn = "0340-6717",
publisher = "Springer Verlag",
number = "1",

}

TY - JOUR

T1 - A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels

AU - Sabater-Lleal, Maria

AU - Buil, Alfonso

AU - Souto, Juan Carlos

AU - Alamsy, Laura

AU - Borrell, Montserrat

AU - Lathrop, Mark

AU - Blangero, John

AU - Fontcuberta, Jordi

AU - Soria, José Manuel

PY - 2008/8

Y1 - 2008/8

N2 - Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) is a protein that potently attenuates fibrinolysis. A considerable proportion of its variability levels is genetically determined. It has been associated with arterial and venous thrombosis. We conducted a Genome Wide Scan for genes affecting variation in plasma TAFI levels in 398 subjects from 21 extended Spanish families. The data were analyzed by a variance-component linkage method. A strong linkage signal was found on the long arm of Chromosome 13, near the DNA marker D13S156, where the structural gene encoding for TAFI is located. In addition, other new linkage signals were detected on chromosome regions 5p and 7q. More importantly, we performed another multipoint linkage analysis of functional TAFI conditioned on TAFI antigen levels. We detected a strong linkage signal on Chromosome 19 (LOD = 3.0, P = 0.0001) suggesting a novel QTL in this region involved in the specific functional activity of TAFI, regardless of the TAFI antigen levels. One notable aspect of this study is the identification of new QTLs that reveal a clearer picture of the genetic determinants responsible for variation in TAFI levels. Another is the replication of the linkage signal of the CPB2 gene, which confirms an important genetic determinant for TAFI antigen levels. These results strongly suggest an oligogenic mode of inheritance for TAFI, in which CPB2 gene accounts for a proportion of the variation of the phenotype together with other unknown genes that may represent potential risk factors for thrombotic disease.

AB - Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) is a protein that potently attenuates fibrinolysis. A considerable proportion of its variability levels is genetically determined. It has been associated with arterial and venous thrombosis. We conducted a Genome Wide Scan for genes affecting variation in plasma TAFI levels in 398 subjects from 21 extended Spanish families. The data were analyzed by a variance-component linkage method. A strong linkage signal was found on the long arm of Chromosome 13, near the DNA marker D13S156, where the structural gene encoding for TAFI is located. In addition, other new linkage signals were detected on chromosome regions 5p and 7q. More importantly, we performed another multipoint linkage analysis of functional TAFI conditioned on TAFI antigen levels. We detected a strong linkage signal on Chromosome 19 (LOD = 3.0, P = 0.0001) suggesting a novel QTL in this region involved in the specific functional activity of TAFI, regardless of the TAFI antigen levels. One notable aspect of this study is the identification of new QTLs that reveal a clearer picture of the genetic determinants responsible for variation in TAFI levels. Another is the replication of the linkage signal of the CPB2 gene, which confirms an important genetic determinant for TAFI antigen levels. These results strongly suggest an oligogenic mode of inheritance for TAFI, in which CPB2 gene accounts for a proportion of the variation of the phenotype together with other unknown genes that may represent potential risk factors for thrombotic disease.

UR - http://www.scopus.com/inward/record.url?scp=46949083746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46949083746&partnerID=8YFLogxK

U2 - 10.1007/s00439-008-0527-3

DO - 10.1007/s00439-008-0527-3

M3 - Article

VL - 124

SP - 81

EP - 88

JO - Human Genetics

JF - Human Genetics

SN - 0340-6717

IS - 1

ER -